學系成員

1. Yang KL, Yu YB, Lin SC, Lin PY. Detection of the HLA-DQB1*06:02:43 allele in a Taiwanese leukemic patient. HLA. 2021 Apr 21 epub 

2. Chang YY, Chang CH, Ku WW, Gau JP, Yu YB*. Tumor lysis syndrome as a risk factor for very early mortality in HIV-associated non-Hodgkin's lymphoma: A 10-year single-center experience. J Chin Med Assoc. 2020 Apr;83(4):371-376. 

3. Kuo KH, Yu YB, Lai TH. Cerebral microbleeds associated with critical illness. Acta Neurol Taiwan. 2019 Mar 15;28(1):25-26. 

4. Hsieh CH, Tien HJ, Yu YB, Wu YH, Shueng PW, Lu YF, Wang SY, Wang LY. Simultaneous integrated boost with helical arc radiotherapy of total skin (HEARTS) to treat cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia - dosimetry comparison of different regimens and clinical application. Radiat Oncol. 2019 Jan 28;14(1):17. 

5. Chen CT, Liu CY, Yu YB, Liu CJ, Hsiao LT, Gau JP, Chiou TJ, Liu JH, Liu YC. Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients. PLoS One. 2017 Sep 21;12(9):e0185210. 

6. Ko PS, Yu YB, Liu YC, Wu YT, Hung MH, Gau JP, Liu CJ, Hsiao LT, Chen PM, Chiou TJ, Liu CY, Liu JH. Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib. Curr Med Res Opin. 2017 Oct;33(10):1737-1744. 

7. Ko PS, Liu YC, Wang HY, Wu CY, Fan NW, Liu CJ, Yu YB, Hsiao LT, Chiou TJ, Tzeng CH, Liu JH, Gau JP. Clinical-associated characteristics and microbiological features of bloodstream nontyphoidal salmonella infection in adult patients receiving allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2017 Sep;96(9):1533-1540. 

8. Liu CY, Hsieh FS, Chu PY, Tsai WC, Huang CT,  Yu YB, Huang TT, Ko PS, Hung MH, Wang WL, Shiau CW, Chen KF. Carfilzomib induces leukaemia cell apoptosis via inhibiting ELK1/KIAA1524 (Elk-1/CIP2A) and activating PP2A not related to proteasome inhibition. Br J Haematol. 2017 Jun;177(5):726-740. 

9. Ko PS, Liu YC, Yeh CM, Gau JP, Yu YB, Hsiao LT, Tzeng CH, Chen PM, Chiou TJ, Liu CJ, Liu JH. The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification. PLoS One. 2017 Feb 14;12(2):e0172029. 

10. Huang CT, Liu CJ, Ko PS, Liu HT, Yu YB, Hsiao LT, Gau JP, Tzeng CH, Chiou TJ, Liu JH, Yang MH, Huang LJ, Liu CY. Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma. BMC Infect Dis. 2017 Jan 6;17(1):33. 

11. Huang SY, Yu YB, Yeh SP, Chen TY, Kao WY, Chen CC, Wang MC, Lin HY, Lin SF, Lin TH, Hua Y, Puccio-Pick M, DeMarco D, Jacques C, Dunn P. A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan. J Formos Med Assoc. 2017 Sep;116(9):705-710. 

12. Noubouossie DF, Whelihan MF, Yu YB, Sparkenbaugh E, Pawlinski R, Monroe DM, Key NS. In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps. Blood. 2017 Feb 23;129(8):1021-1029. 

13. Yu YB, Su KH, Kou YR, Guo BC, Lee KI, Wei J, Lee TS. Role of transient receptor potential vanilloid 1 in regulating erythropoietin-induced activation of endothelial nitric oxide synthase. Acta Physiol (Oxf). 2017 Feb;219(2):465-477. 

14. Lee GY, Lee YT, Yeh CM, Hsu P, Lin TW, Gau JP, Yu YB, Hsiao LT, Tzeng CH, Chiou TJ, Liu JH, Liu YC, Liu CJ. Risk of stroke in patients with newly diagnosed multiple myeloma: a retrospective cohort study. Hematol Oncol. 2017 Dec;35(4):726-733. 

15. Wang HY, Yang CF, Chiou TJ, Yang SH, Gau JP, Yu YB, Chen PM, Hsu HC, Fung CP, Lin HY, Tzeng CH, Liu JH, Hsiao LT. Risk of hemophagocytic lymphohistiocytosis in adults with fevers of unknown origin: the clinical utility of a new scoring system on early detection. Hematol Oncol. 2017 Dec;35(4):835-844. 

16. Wu CY, Chiou TJ, Liu CY, Lin FC, Lin JS, Hung MH, Hsiao LT, Yen CC, Gau JP, Yen HJ, Hung GY, Hsu HC, Tzeng CH, Liu JH, Yu YB*, Decision-tree algorithm for optimized hematopoietic progenitor cell-based predictions in peripheral blood stem cell mobilization. Transfusion. 2016 Aug;56(8):2042-51. (Corresponding author) 

17. Liu YC, Chien SH, Fan NW, Hu MH, Gau JP, Liu CJ, Yu YB, Hsiao LT, Chiou TJ, Tzeng CH, Chen PM, Liu JH. Prognostic Factors on the Graft-versus-Host Disease-Free and Relapse-Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation. Stem Cells Int. 2016;2016:5143071. 

18. Hsiao LT, Wang HY, Yang CF, Chiou TJ, Gau JP, Yu YB, Liu HL, Chang WC, Chen PM, Tzeng CH, Chan YJ, Yang MH, Liu JH, Huang YH. Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients. Medicine (Baltimore). 2016 Mar;95(11):e3064. 

19. Hsu P, Lin TW, Gau JP, Yu YB, Hsiao LT, Tzeng CH, Chen PM, Chiou TJ, Liu JH, Liu YC, Liu CJ. Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma. Medicine (Baltimore). 2015 Dec;94(50):e2305. 

20. Hsiao LT, Chiou TJ, Gau JP, Yang CF, Yu YB, Liu CY, Liu JH, Chen PM, Tzeng CH, Chan YJ, Yang MH, Huang YH. Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study. Medicine (Baltimore). 2015 Aug;94(32):e1321. 

21. Lee TS, Lu KY,  Yu YB, Lee HT, Tsai FC. β Common Receptor Mediates Erythropoietin-Conferred Protection on OxLDL-Induced Lipid Accumulation and Inflammation in Macrophages. Mediators Inflamm. 2015;2015:439759. 

22. Gau JP, Chen CC, Chou YS, Liu CJ, Yu YB, Hsiao LT, Liu JH, Hsu HC, Chiou TJ, Chen PM, Tzeng CH. No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutation. Blood Cells Mol Dis. 2015 Jun;55(1):36-9. 

23. Liu YC, Chien SH, Fan NW, Hu MH, Gau JP, Liu CJ, Yu YB, Liu CY, Hsiao LT, Liu JH, Chiou TJ, Tzeng CH. Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2015 Jun;169(5):737-45. 

24. Yang SH, Hsiao LT, Chiou TJ, Yang CF, Yu YB, Liu CY, Gau JP, Liu JH, Chen PM, Tzeng CH. Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma. J Chin Med Assoc. 2015 Jul;78(7):400-7. 

25. Liu YC, Chien SH, Fan NW, Hu MH, Gau JP, Liu CJ, Yu YB, Liu CY, Hsiao LT, Liu JH, Chiou TJ, Chen PM, Tzeng CH. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation. J Microbiol Immunol Infect. 2016 Aug;49(4):567-74. 

26. Wu CY, Hsiao LT, Chiou TJ, Gau JP, Liu JH, Yu YB, Wu YT, Liu CJ, Huang YC, Hung MH, Chen PM, Huang YH, Tzeng CH. Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B. Leuk Lymphoma. 2015;56(8):2357-64